Reliability and Validity of a New Ankle Dorsiflexion Lunge Test Using a Level Laser.
Launched by UNIVERSITY OF BOLOGNA · May 31, 2022
Trial Information
Current as of May 02, 2025
Unknown status
Keywords
ClinConnect Summary
The dorsiflexion lunge test or knee-to-wall test (DLT) measure the range of movement of weight bearing ankle dorsiflexion. This test is frequently used in sport setting, in order to identify ankle limitations which could lead to possible injuries or joint overloads.
DLT is a cheap and simple measurement method to assess the ankle dorsiflexion, however clinicians find possible bias that reduce the usability of this test.
In order to remove this bias, this study suggests a new measurement method carried out by a level laser to create a virtual wall (the vertical red line produced by the las...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • male teenagers basketball players enrolled in a competitive sports club;
- • teenagers whose parents have signed the privacy and consent forms.
- Exclusion Criteria:
- • athletes who have suffered in the last 3 months of lower limb musculoskeletal disorders such as pain for more than 7 days (ankle distortion outcomes, leg/foot fractures, plantar heel pain, metatarsalgias, etc);
- • athletes who have undergone surgery on their lower limb.
About University Of Bologna
The University of Bologna, one of the oldest and most prestigious academic institutions in the world, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical research. With a strong emphasis on interdisciplinary collaboration and cutting-edge methodologies, the university sponsors a diverse range of clinical trials aimed at enhancing patient outcomes and contributing to the scientific community. Its commitment to ethical standards and regulatory compliance ensures that all trials are conducted with the utmost integrity, fostering an environment of trust and excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, , Italy
Patients applied
Trial Officials
Tommaso Torriglia
Principal Investigator
Università degli studi di Bologna
Pillastrini Paolo
Study Director
Università degli studi di Bologna
Silvia Pozzan
Study Chair
Università degli studi di Bologna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials